You are here: Industry Insights > Immunology

News List

Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
October 18, 2024
Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.
I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board prnasia
December 02, 2020
I-Mab announced the strengthening of its Scientific Advisory Board with the appointment of leading international experts Dr. Chen Dong and Dr. Jun Ma.
Alpine Immune and AbbVie sign $865m immunology deal pharmaceutical-technology
June 22, 2020
Clinical-stage immunotherapy firm Alpine Immune Sciences and biopharmaceutical company AbbVie have signed an option and license agreement potentially worth $805m, for ALPN-101 drug.
Pneumagen Appoints Scientific Advisory Board americanpharmaceuticalreview
September 03, 2019
Pneumagen announced appointments to its Scientific Advisory Board (SAB), adding expertise in the areas of respiratory disease, immunology and oncology.
Study Examines Use of Electronic Consults for Allergy/Immunology drugs
June 18, 2019
Study Examines Use of Electronic Consults for Allergy/Immunology.
Asthma Myths That Can Hurt You drugs
April 24, 2019
Even though asthma is common in the United States, there are many misconceptions about the respiratory disease, an allergy/immunology expert says.
Lilly, Avidity Biosciences Enter Global R&D Alliance b3cnewswire
April 23, 2019
Will leverage Avidity's technology platform for the discovery, development and commercialization of potential new medicines in immunology and other indications...
Lilly and ImmuNext enter autoimmune disease research alliance pharmaceutical-technology
April 11, 2019
Lilly and ImmuNext enter autoimmune disease research alliance.
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval fiercepharma
March 27, 2019
As Humira heads toward the end of its exclusive life in the U.S. and faces new competition in Europe, AbbVie is set for its next blockbuster launch thanks to an approval in Japan.
AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children drugs
February 28, 2019
Egg-allergic children who undergo egg oral immunotherapy (eOIT) and achieve sustained unresponsiveness (SU) eat more egg and have fewer symptoms five years later....

Previous page 1 2 3 Next page